Joli D. Cerveny

Use of Fenofibrate in the Management of Protease Inhibitor‐Associated Lipid Abnormalities

James C. Thomas, Maria F. Lopes‐Virella, Victor E. Del Bene et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2000 · 51 citations

National Pharmacy Cardiovascular Council Treatment Guidelines for the Management of Type 2 Diabetes Mellitus: Toward Better Patient Outcomes and New Roles for Pharmacists

David Hawkins, J. Chris Bradberry, Mark J. Cziraky et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2002 · 35 citations

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +8

Enhanced Metabolism of Levonorgestrel During Phenobarbital Treatment and Resultant Pregnancy

Laura Shane‐McWhorter, Joli D. Cerveny, Lori L. MacFarlane et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 1998 · 34 citations

Experience with Objective Structured Clinical Examinations as a Participant Evaluation Instrument in Disease Management Certificate Programs

Joli D. Cerveny, Rebecca G. Knapp, Mario DelSignore et al. · American Journal of Pharmaceutical Education · 1999 · 12 citations

Diagnostic Criterion, Patient Safety, Diagnosis +12

An Interdisciplinary Effort to Help Patients With Limited Prescription Drug Benefits Afford Their Medication

Joli D. Cerveny, Lori L. MacFarlane · Southern Medical Journal · 1998 · 10 citations